文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

低潮气量与中等潮气量通气策略对无ARDS的ICU患者无呼吸机天数的影响:一项随机临床试验

Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS: A Randomized Clinical Trial.
PubMed 文献 · JAMA · 2018-01-01
一句话结论在无ARDS且预期24小时内不能拔管的ICU患者中,低潮气量策略并未比中等潮气量策略带来更多无呼吸机天数(中位数均为21天,平均差-0.27,95%CI -1.74至1.19,P=0.71)。

该随机临床试验于2014年9月1日至2017年8月20日在荷兰6个ICU进行,纳入无ARDS且预期开始通气后24小时内不能拔管的患者,随机接受低潮气量(n=477)或中等潮气量(n=484)有创通气。主要终点为28天无呼吸机且存活天数,低潮气量组中位数21天(IQR 0-26),中等潮气量组中位数21天(IQR 0-26),平均差-0.27(95%CI -1.74至1.19;P=0.71)。ICU住院时间、医院住院时间、28天和90天死亡率及ARDS、肺炎、严重肺不张、气胸发生率均无显著差异。结论:在无ARDS且预期24小时内不能拔管的ICU患者中,低潮气量策略并未比中等潮气量策略增加无呼吸机天数。

要点

  • 无ARDS且预期24小时内不能拔管的ICU患者中,低潮气量组与中等潮气量组28天无呼吸机天数中位数均为21天(IQR 0-26),平均差-0.27(95%CI -1.74至1.19;P=0.71),无显著差异。
  • 两组ICU住院时间中位数均为6天(差0.39,95%CI -1.09至1.89;P=0.58),医院住院时间中位数14天 vs 15天(差-0.60,95%CI -3.52至2.31;P=0.68),均无显著差异。
  • 28天死亡率低潮气量组34.9% vs 中等潮气量组32.1%(HR 1.12,95%CI 0.90至1.40;P=0.30),90天死亡率39.1% vs 37.8%(HR 1.07,95%CI 0.87至1.31;P=0.54),均无显著差异。
  • 不良事件方面,ARDS发生率3.8% vs 5.0%(RR 0.86,95%CI 0.59至1.24;P=0.38),肺炎4.2% vs 3.7%(RR 1.07,95%CI 0.78至1.47;P=0.67),严重肺不张11.4% vs 11.2%(RR 1.00,95%CI 0.81至1.23;P=0.94),气胸1.8% vs 1.3%(RR 1.16,95%CI 0.73至1.84;

适用人群与场景

  • 纳入无ARDS且预期开始通气后24小时内不能拔管的ICU患者,来自荷兰6个ICU,共961例(65%男性),中位年龄68岁(IQR 59-76)。

研究设计与关键结果

  • 研究类型为随机临床试验,2014年9月1日至2017年8月20日在荷兰6个ICU进行,纳入961例无ARDS且预期24小时内不能拔管的患者,随机接受低潮气量(n=477)或中等潮气量(n=484)有创通气。
  • 主要终点28天无呼吸机且存活天数:低潮气量组475例可评估,中位数21天(IQR 0-26);中等潮气量组480例可评估,中位数21天(IQR 0-26);平均差-0.27(95%CI -1.74至1.19;P=0.71)。
  • ICU住院时间中位数低潮气量组6天 vs 中等潮气量组6天(差0.39,95%CI -1.09至1.89;P=0.58);医院住院时间中位数14天 vs 15天(差-0.60,95%CI -3.52至2.31;P=0.68)。
  • 28天死亡率低潮气量组34.9% vs 中等潮气量组32.1%(HR 1.12,95%CI 0.90至1.40;P=0.30);90天死亡率39.1% vs 37.8%(HR 1.07,95%CI 0.87至1.31;P=0.54)。
  • ARDS发生率低潮气量组3.8% vs 中等潮气量组5.0%(RR 0.86,95%CI 0.59至1.24;P=0.38);肺炎4.2% vs 3.7%(RR 1.07,95%CI 0.78至1.47;P=0.67);严重肺不张11.4% vs 11.2%(RR 1.00,95%CI 0.81至1.23;P=0.94);气胸1.8% vs 1.3%(RR 1.16,95%CI 0.73至1.84;P=0.55)。

证据类型、等级与局限

  • 证据类型:随机临床试验(RCT),注册号NCT02153294。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在无ARDS且预期24小时内不能拔管的ICU患者中,低潮气量策略与中等潮气量策略相比,28天无呼吸机天数、住院时间、死亡率及不良事件发生率均无显著差异,提示该人群中选择低潮气量策略并未带来额外获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: It remains uncertain whether invasive ventilation should use low tidal volumes in critically ill patients without acute respiratory distress syndrome (ARDS).

OBJECTIVE: To determine whether a low tidal volume ventilation strategy is more effective than an intermediate tidal volume strategy.

DESIGN, SETTING, AND PARTICIPANTS: A randomized clinical trial, conducted from September 1, 2014, through August 20, 2017, including patients without ARDS expected to not be extubated within 24 hours after start of ventilation from 6 intensive care units in the Netherlands.

INTERVENTIONS: Invasive ventilation using low tidal volumes (n = 477) or intermediate tidal volumes (n = 484).

MAIN OUTCOMES AND MEASURES: The primary outcome was the number of ventilator-free days and alive at day 28. Secondary outcomes included length of ICU and hospital stay; ICU, hospital, and 28- and 90-day mortality; and development of ARDS, pneumonia, severe atelectasis, or pneumothorax.

RESULTS: In total, 961 patients (65% male), with a median age of 68 years (interquartile range [IQR], 59-76), were enrolled. At day 28, 475 patients in the low tidal volume group had a median of 21 ventilator-free days (IQR, 0-26), and 480 patients in the intermediate tidal volume group had a median of 21 ventilator-free days (IQR, 0-26) (mean difference, -0.27 [95% CI, -1.74 to 1.19]; P = .71). There was no significant difference in ICU (median, 6 vs 6 days; 0.39 [-1.09 to 1.89]; P = .58) and hospital (median, 14 vs 15 days; -0.60 [-3.52 to 2.31]; P = .68) length of stay or 28-day (34.9% vs 32.1%; hazard ratio [HR], 1.12 [0.90 to 1.40]; P = .30) and 90-day (39.1% vs 37.8%; HR, 1.07 [0.87 to 1.31]; P = .54) mortality. There was no significant difference in the percentage of patients developing the following adverse events: ARDS (3.8% vs 5.0%; risk ratio [RR], 0.86 [0.59 to 1.24]; P = .38), pneumonia (4.2% vs 3.7%; RR, 1.07 [0.78 to 1.47]; P = .67), severe atelectasis (11.4% vs 11.2%; RR, 1.00 [0.81 to 1.23]; P = .94), and pneumothorax (1.8% vs 1.3%; RR, 1.16 [0.73 to 1.84]; P = .55).

CONCLUSIONS AND RELEVANCE: In patients in the ICU without ARDS who were expected not to be extubated within 24 hours of randomization, a low tidal volume strategy did not result in a greater number of ventilator-free days than an intermediate tidal volume strategy.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02153294.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Simonis FD, Serpa Neto A, Binnekade JM, et al. Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS: A Randomized Clinical Trial. JAMA. 2018. PMID: 30357256. doi:10.1001/jama.2018.14280

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。